MarketCapTrends
SNDX
Syndax Pharmaceuticals Inc. (SNDX)
NASDAQ · Healthcare

Syndax Pharmaceuticals Inc. Cash on Hand 2015–2025

Syndax Pharmaceuticals Inc. annual/quarterly cash on hand history from 2015 to 2025. Cash on hand refers to the total amount of cash and cash equivalents held by a company.

  • Syndax Pharmaceuticals Inc. cash on hand for the quarter ending December 31, 2025 were 134.9M, a 12.43% decrease year-over-year.
  • Syndax Pharmaceuticals Inc. cash on hand for 2025 were 134.9M, a 12.43% decrease from 2024.
  • Syndax Pharmaceuticals Inc. cash on hand for 2024 were 154.1M, a 47.84% decrease from 2023.
  • Syndax Pharmaceuticals Inc. cash on hand for 2023 were 295.4M, a 297.27% increase from 2022.
  • Syndax Pharmaceuticals Inc. cash on hand for 2022 were 74.4M.
Cash on Hand
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
Syndax Pharmaceuticals Inc. Annual Cash on Hand (Millions of US $)
2025$135
2024$154
2023$295
2022$74
2021$222
2020$115
2019$25
2018$34
2017$35
2016$24
2015$23
Syndax Pharmaceuticals Inc. Quarterly Cash on Hand (Millions of US $)
2025-12-31$135
2024-12-31$154
2023-12-31$295
2022-12-31$74
2021-12-31$222
2020-12-31$115
2019-12-31$25
2018-12-31$34
2017-12-31$35
2016-12-31$24
2015-12-31$23

Syndax Pharmaceuticals Inc. Cash on Hand — FAQ

Syndax Pharmaceuticals Inc. (SNDX) cash on hand over the last 11 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see SNDX's cash on hand history?

The chart and table above show Syndax Pharmaceuticals Inc.'s cash on hand by year and by quarter, including the growth rate.